Tenax Therapeutics Awards 657,500 Stock Options to Four New Hires

Tenax Therapeutics announced it has awarded or will award inducement stock options totaling 657,500 shares of common stock to four newly hired non-executive individuals. These awards are for various clinical operations, medical, product development, and commercial roles. The options, with an exercise price equal to the closing price on each employee's start date, will vest over approximately four years, with 25% on the first anniversary and the remainder monthly thereafter. The Board's Compensation Committee approved these awards as material inducements for employment, granted outside the stockholder-approved equity incentive plan.